UY26371A1 - Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen - Google Patents

Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen

Info

Publication number
UY26371A1
UY26371A1 UY26371A UY26371A UY26371A1 UY 26371 A1 UY26371 A1 UY 26371A1 UY 26371 A UY26371 A UY 26371A UY 26371 A UY26371 A UY 26371A UY 26371 A1 UY26371 A1 UY 26371A1
Authority
UY
Uruguay
Prior art keywords
preparation
imidazo
biciclicas
aminas
medicines
Prior art date
Application number
UY26371A
Other languages
English (en)
Inventor
Matthias Gerlach Matth Gerlach
Corinna Maul
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1999148437 external-priority patent/DE19948437A1/de
Priority claimed from DE19948434A external-priority patent/DE19948434A1/de
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of UY26371A1 publication Critical patent/UY26371A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Imidazo-3-il-aminas bicíclicas de la fórmula general I en forma de sus bases o sales farmacéuticamente aceptables, procedimiento para su preparación y medicamento que contiene como sustancia activa al menos una amidazol-3-il-amina bicíclica de la fórmula general I en forma de su base o una sal farmacéuticamente aceptable.
UY26371A 1999-10-08 2000-10-05 Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen UY26371A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1999148437 DE19948437A1 (de) 1999-10-08 1999-10-08 Am Sechsring substituierte, bicyclische Imidazo-3-aminderivate
DE19948434A DE19948434A1 (de) 1999-10-08 1999-10-08 Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine

Publications (1)

Publication Number Publication Date
UY26371A1 true UY26371A1 (es) 2000-10-31

Family

ID=26055217

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26371A UY26371A1 (es) 1999-10-08 2000-10-05 Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen

Country Status (27)

Country Link
US (1) US6849642B2 (es)
EP (1) EP1218380B1 (es)
JP (1) JP2003517466A (es)
KR (1) KR20020038804A (es)
CN (1) CN1222525C (es)
AR (1) AR025961A1 (es)
AT (1) ATE256684T1 (es)
AU (1) AU780823B2 (es)
BR (1) BR0014826A (es)
CA (1) CA2386813C (es)
CO (1) CO5210870A1 (es)
CZ (1) CZ300315B6 (es)
DE (1) DE50004817D1 (es)
DK (1) DK1218380T3 (es)
ES (1) ES2213044T3 (es)
HK (1) HK1047748B (es)
HU (1) HUP0203739A3 (es)
IL (2) IL148998A0 (es)
MX (1) MXPA02003547A (es)
NO (1) NO20021563L (es)
NZ (1) NZ518637A (es)
PE (1) PE20010631A1 (es)
PT (1) PT1218380E (es)
RU (1) RU2002110282A (es)
SK (1) SK286450B6 (es)
UY (1) UY26371A1 (es)
WO (1) WO2001027110A2 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10043845A1 (de) * 2000-09-06 2002-03-14 Gruenenthal Gmbh Verfahren zur Messung der Aktivität der NO-Synthase
EP1343785A2 (de) * 2000-12-13 2003-09-17 Basf Aktiengesellschaft Verwendung von substituierten imidazoazinen, neue imidazoazine, verfahren zu deren herstellung, sowie sie enthaltende mittel
US7157460B2 (en) 2003-02-20 2007-01-02 Sugen Inc. Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
US7186832B2 (en) 2003-02-20 2007-03-06 Sugen Inc. Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
DE102004021716A1 (de) * 2004-04-30 2005-12-01 Grünenthal GmbH Substituierte Imidazo[1,2-a]pyridin-Verbindungen und Arzneimittel enthaltend substituierte Imidazo[1,2-a]pyridin-Verbindungen
DE102004044884A1 (de) * 2004-09-14 2006-05-24 Grünenthal GmbH Substituierte bizyklische Imidazo-3-yl-amin-Verbindungen
DE102005016547A1 (de) * 2005-04-08 2006-10-12 Grünenthal GmbH Substituierte 5,6,7,8-Tetrahydro-imidazo(1,2-a)pyridin-2-ylamin-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
EP1928237A4 (en) 2005-09-02 2011-03-09 Abbott Lab NEW HETEROCYCLES BASED ON IMIDAZO
CA2653506A1 (en) * 2006-05-31 2007-12-06 Galapagos Nv. Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases
WO2008134553A1 (en) * 2007-04-26 2008-11-06 Xenon Pharmaceuticals Inc. Methods of using bicyclic compounds in treating sodium channel-mediated diseases
US8053574B2 (en) 2007-07-18 2011-11-08 Novartis Ag Organic compounds
US8119809B2 (en) 2007-11-16 2012-02-21 Rigel Pharmaceuticals, Inc. AMPK-activating heterocycloalkyloxy(hetero)aryl carboxamide, sulfonamide and amine compounds and methods for using the same
JP5650540B2 (ja) 2007-12-12 2015-01-07 ライジェル ファーマシューティカルズ， インコーポレイテッド 代謝障害のためのカルボキサミド、スルホンアミド、およびアミン化合物
PT2266990E (pt) * 2008-04-15 2012-12-27 Eisai R&D Man Co Ltd Composto de 3-fenilpirazolo[5,1-b]tiazole
JP5658138B2 (ja) 2008-04-23 2015-01-21 ライジェル ファーマシューティカルズ， インコーポレイテッド 代謝障害の処置のためのカルボキサミド化合物
CN102216298B (zh) * 2008-09-16 2014-04-16 Csir公司 作为hiv-1逆转录酶抑制剂的咪唑并吡啶和咪唑并嘧啶
EP2417136B1 (en) * 2009-04-07 2016-01-06 University Of Witwatersrand, Johannesburg Imidazo [1,2-a] pyridine-6-carboxamide derivatives, their use for the treatment of colon cancer and their method of manufacture
AR078521A1 (es) * 2009-10-08 2011-11-16 Eisai R&D Man Co Ltd Compuesto pirazolotiazol
SG184073A1 (en) * 2010-03-18 2012-10-30 Pasteur Institut Korea Anti-infective compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489755A (en) 1966-08-03 1970-01-13 Pfizer & Co C Imidazo (1,2-b) pyridazines
DE3269604D1 (en) 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
NZ221996A (en) * 1986-10-07 1989-08-29 Yamanouchi Pharma Co Ltd Imidazo-pyridine derivatives and pharmaceutical compositions
TW274551B (es) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
CN1064360C (zh) * 1995-04-21 2001-04-11 新日本药品株式会社 稠合咪唑并[1,2－a]吡啶类

Also Published As

Publication number Publication date
CZ20021243A3 (cs) 2003-12-17
AU7519900A (en) 2001-04-23
HK1047748A1 (en) 2003-03-07
BR0014826A (pt) 2002-08-27
MXPA02003547A (es) 2002-09-18
ES2213044T3 (es) 2004-08-16
EP1218380B1 (de) 2003-12-17
CO5210870A1 (es) 2002-10-30
NZ518637A (en) 2004-12-24
HUP0203739A2 (hu) 2003-02-28
IL148998A (en) 2006-12-31
PE20010631A1 (es) 2001-07-07
HK1047748B (zh) 2004-10-21
CA2386813C (en) 2008-09-02
AR025961A1 (es) 2002-12-26
CN1222525C (zh) 2005-10-12
WO2001027110A2 (de) 2001-04-19
JP2003517466A (ja) 2003-05-27
KR20020038804A (ko) 2002-05-23
AU780823B2 (en) 2005-04-21
US20020183327A1 (en) 2002-12-05
WO2001027110A3 (de) 2001-09-20
RU2002110282A (ru) 2003-12-20
PL364866A1 (en) 2004-12-27
IL148998A0 (en) 2002-11-10
SK286450B6 (sk) 2008-10-07
EP1218380A2 (de) 2002-07-03
US6849642B2 (en) 2005-02-01
PT1218380E (pt) 2004-05-31
DK1218380T3 (da) 2004-03-15
NO20021563L (no) 2002-06-04
NO20021563D0 (no) 2002-04-03
DE50004817D1 (de) 2004-01-29
SK4612002A3 (en) 2002-09-10
CN1402727A (zh) 2003-03-12
CA2386813A1 (en) 2001-04-19
ATE256684T1 (de) 2004-01-15
CZ300315B6 (cs) 2009-04-15
HUP0203739A3 (en) 2004-07-28

Similar Documents

Publication Publication Date Title
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
UY26371A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen
AR033423A1 (es) Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos
HN2000000224A (es) Aminoacidos biciclicos como agentes farmaceuticos
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
AR006678A1 (es) Derivados de macrolidas triciclicas, una composicion farmaceutica que los contiene, uso de los mismos para preparar medicamentos y procedimientopara su preparacion
AR005458A1 (es) 2-oxo-y 2-tio-1,2-dihidroquinolinil-oxazolidinonas, procedimiento para su produccion, el uso de las mismas para la produccion de un medicamento ymedicamentos que los contienen
AR023972A1 (es) Composiciones de medicamentos a base de compuestos anticolinergicamente activos y beta-mimeticos
AR029175A1 (es) Derivados 2-amino-fenilpurina, un proceso para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la preparacion de un medicamento
AR032293A1 (es) Estuche farmaceutico
CY1107675T1 (el) Φαρμακευτικα αλατα τραμαδολης
ECSP056246A (es) DERIVADOS DE PIRROLO [3,4-c]PIRAZOL ACTIVOS COMO INHIBIDORES DE QUINASA
MX9301348A (es) Nuevos compuestos que tienen actividad farmacologica, proceso para su preparacion y composicion farmaceutica que los comprende.
AR034897A1 (es) Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos
SE8602723D0 (sv) Thiazoles, their production and pharmaceutical compositions containing them
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
ES2034926T1 (es) Composiciones farmaceuticas orales liquidas con actividad anti-inflamatoria.
ES2145360T3 (es) Sales cristalinas y estables de acido tetrahidrofolico.
DE69813263D1 (de) Hydrazono-benzazulen-derivate, pharmazeutische zusammensetzungen und zwischenprodukte
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
AR013559A1 (es) USO DE DERIVADOS DE PIRROLIDINA PARA LA PREPARACIoN DE MEDICAMENNTOS DESTINADOS AL TRATAMIENTO DEL ABUSO DE DROGAS O DE SUSTANCIAS QUE DAN ORIGEN A LA ADICCIoN O AL USO EXCESIVO DE DROGAS , CON EXCEPCIoN DEL ABUSO DEL ALCOHOL, MEDIANTE LA REDUCCIoN DE LA AUTO-MEDICACIoN DE DICHAS DROGAS POR PARTE DE
AR023452A1 (es) Utilizacion del osanetant para preparacion de medicamentos utiles en el tratamiento de los trastornos del humor
ECSP003693A (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen
ECSP003692A (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20121227